Patents by Inventor Celine M. Laffont

Celine M. Laffont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Buprenorphine dosing regimens
    Patent number: 11839611
    Abstract: The disclosure provides a dosage regimen using sustained-release buprenorphine formulations to produce therapeutic levels of buprenorphine in patients for the treatment of pain or opioid use disorders.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: December 12, 2023
    Assignee: Indivior UK Limited
    Inventors: Azmi Nasser, Celine M. Laffont, Christian A. Heidbreder
  • BUPRENORPHINE DOSING REGIMENS
    Publication number: 20230077787
    Abstract: The disclosure provides a dosage regimen using sustained-release buprenorphine formulations to produce therapeutic levels of buprenorphine in patients for the treatment of pain or opioid use disorders.
    Type: Application
    Filed: November 11, 2022
    Publication date: March 16, 2023
    Applicant: Indivior UK Limited
    Inventors: Azmi NASSER, Celine M. LAFFONT, Christian A. HEIDBREDER
  • BUPRENORPHINE DOSING REGIMENS
    Publication number: 20220031692
    Abstract: The disclosure provides a dosage regimen using sustained-release buprenorphine formulations to produce therapeutic levels of buprenorphine in patients for the treatment of pain or opioid use disorders.
    Type: Application
    Filed: March 30, 2021
    Publication date: February 3, 2022
    Applicant: Indivior UK Limited
    Inventors: Azmi NASSER, Celine M. LAFFONT, Christian A. HEIDBREDER
  • Buprenorphine dosing regimens
    Patent number: 11000520
    Abstract: The disclosure provides a dosage regimen using sustained-release buprenorphine formulations to produce therapeutic levels of buprenorphine in patients for the treatment of pain or opioid use disorders.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: May 11, 2021
    Assignee: Indivior UK Limited
    Inventors: Azmi Nasser, Celine M Laffont, Christian Heidbreder
  • Methods to treat opioid use disorder
    Patent number: 10646484
    Abstract: The disclosure provides sustained-release buprenorphine formulations that produce therapeutic plasma concentration levels of buprenorphine in patients to treat opioid use disorder.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: May 12, 2020
    Assignee: INDIVIOR UK LIMITED
    Inventors: Celine M. Laffont, Malcolm A. Young, Norma L. Fox, Barbara R. Haight, Susan M. Learned
  • METHODS TO TREAT OPIOID USE DISORDER
    Publication number: 20180360821
    Abstract: The disclosure provides sustained-release buprenorphine formulations that produce therapeutic plasma concentration levels of buprenorphine in patients to treat opioid use disorder.
    Type: Application
    Filed: June 22, 2018
    Publication date: December 20, 2018
    Inventors: Celine M. Laffont, Malcolm A. Young, Norma L. Fox, Barbara R. Haight, Susan M. Learned